myTomorrows
@myTomorrowsmyTomorrows is a platform that links physicians and their patients facing unmet medical needs to treatments in development worldwide
Similar User
@ourmbclife
@vitaccess
@RarePOV
@Science37x
@aHUSAllianceAct
@srqstockpicker
@EMoriartyWade
@womenofteal
@J2Novack
@chemobrainfog
🌍Today is World Pancreatic Cancer Day (#WPCD)! Together with our partner @PCE, we aim to support those affected, helping them explore and access all possible treatment options, including clinical trials. Discover more: eu1.hubs.ly/H0dVbnk0
Missed our last Q&A with @brainstrust? Join us on Nov 28 at 12:30pm CET / 11:30am UK for the High-Grade Knowledge Share session “Discovering and Accessing Clinical Trials: How Patient Navigators Support You.” Register here: eu1.hubs.ly/H0dNP360 #braincancer #clinicaltrials
Are you searching for a #newjob with an important mission? 🌍 Join us: ✔️Backend Engineer: eu1.hubs.ly/H0dNGX20 ✔️Senior Backend Engineer: eu1.hubs.ly/H0dNDpy0 ✔️Senior DevOps Engineer: eu1.hubs.ly/H0dND290 👉Full list: eu1.hubs.ly/H0dND2b0 #hiring
☀️Join us TODAY at 6:00 pm CET/12:00 pm ET for our panel discussion on "Supporting Pediatric Patient Populations: The Case for Expanded Access". Learn about how #EAPs can help overcome treatment gaps in pediatric care. Register: eu1.hubs.ly/H0dFSlp0 #BioPharma #PediatricCare
🌏 On this #WorldDiabetesDay, we highlight the need for accessible and affordable care for everyone affected. At myTomorrows, we strive to break down barriers that prevent people from discovering and accessing all possible treatment options. Read more: eu1.hubs.ly/H0dKrxL0
We’re thrilled to welcome Vanessa Lemarié as the new COO at @myTomorrows! ☀️ With 15+ years of healthcare leadership at Bayer & Ada Health, Vanessa will lead operations, overseeing our engagements with patients, physicians, and pharma. ➡️Read more here: eu1.hubs.ly/H0dFNPM0
Just 1 week left until our panel discussion on Supporting Pediatric Patient Populations: The Case for Expanded Access. 🚀 📗Day: 14th November 🕕Time: 6:00 pm CET / 12:00 pm ET 👉 Secure your spot here! eu1.hubs.ly/H0dytxk0 #PediatricCare #BioPharma #ExpandedAccess
Becker Muscular Dystrophy (#BMD) causes progressive muscle weakness, affecting ~0.8-6 per 100,000 people globally. Our blog discusses causes, symptoms, diagnosis & lifestyle management options for this condition. Read here: eu1.hubs.ly/H0dxcyB0 #BeckerMuscularDystrophy #MD
myTomorrows is a hosting partner of the Patient Recruitment for Rare Disease Trials Summit this year! 🌟 🗒️ Dec 10-12, 2024 📍 Boston 💸 Use our code SPN5038820 for a 20% discount on registration! ➡️ Register: eu1.hubs.ly/H0dtPL10 #RareDisease #ClinicalTrials #PAG
November is #LungCancerAwarenessMonth – a time to support those impacted. For us, this mission is personal: our founder, Ronald Brus, founded myTomorrows after losing his father to lung cancer. ☀️ Book a call to discover your clinical treatment options: eu1.hubs.ly/H0drQ3K0
🛠️ Build your career foundation this Monday—explore your #newjob with us. Join a fast-growing company helping connect patients to clinical trials ✔️Growth Marketer eu1.hubs.ly/H0drqBF0 ✔️Engineering Manager eu1.hubs.ly/H0drnt70 Full list: eu1.hubs.ly/H0drnrs0 #hiring
Join us on 14th Nov at 6:00 pm CET / 12:00 pm ET for a panel discussion on 'Supporting Pediatric Patient Populations: The Case for Expanded Access'. 🚀 Discover challenges in pediatric expanded access and potential solutions. ➡️ Register: eu1.hubs.ly/H0dq1dz0 #BioPharma #EAP
Live from SCOPE Europe in Barcelona! ☀️ Join us at 10:40 AM for Jytte’s talk, "What It Takes to Successfully Recruit Patients: An Integrated Platform Approach." Visit us at booth #49 or schedule a meeting: eu1.hubs.ly/H0dl1Zy0 #SCOPEEurope #ClinicalTrials #PatientEngagement
☀️ It's International Brain Tumour Awareness Week, a time to raise awareness about this condition ☀️ In support, we share a new blog about brain tumours, covering symptoms, diagnosis, and treatment options. eu1.hubs.ly/H0dkgsG0 #BTAW2024 #EndBrainTumours
Excited to share that @PharmExec has published an article featuring insights from our CEO, Michel van Harten, on the role of #DEI in #clinicaltrials. Learn how strategies like tackling key barriers can advance #HealthEquity. ➡️ Visit: eu1.hubs.ly/H0dhDDN0 #biopharma #health
We’re on the ground at the #WODC! ☀️ Angela and Laura are having insightful conversations with biopharma leaders, PAGs, and healthcare professionals. 🚀 ➡️ If you are attending, book a meeting with us: eu1.hubs.ly/H0dfPRh0 #OrphanDrugs #RareDiseases #Biopharma
Counting down to #SCOPE Europe in Barcelona, Oct 29-30! ⌛ ☀️Don’t miss Jytte's talk "What It Takes to Successfully Recruit Patients: An Integrated Platform Approach" on Tuesday, Oct 29, at 10.40 AM. ➡️Book a meeting with us: eu1.hubs.ly/H0dccH00 #ClinicalTrials #BioPharma
📢 Register now for the first-ever 'Pre-approval Access to Medicines in APAC' conference, Feb 18-19, 2025, Singapore. Join expert panels, hear from industry thought leaders and more. eu1.hubs.ly/H0d4ZZg0 Early bird pricing ends Dec 13th🚨 #APAC #BioPharma #conference
🌟 We are looking for two #colleagues to join a fast-growing company of 80+ people, with 30 nationalities, in Amsterdam ✔️Medical Community Operations Specialist eu1.hubs.ly/H0d6zhW0 ✔️Product Analyst eu1.hubs.ly/H0d6Dxr0 eu1.hubs.ly/H0d6Cx40 #newjob #hiring
Our very own Laura, Angela, Jytte, and Molly are attending the #SCOPE Europe Conference on 29-30 October in Barcelona! ☀️ 👉 Visit us at Booth #49 or schedule a meeting: eu1.hubs.ly/H0d52wl0 #ClinicalTrials #Recruitment #BioPharma #HealthcareInnovation
United States Trends
- 1. Auburn 31 B posts
- 2. Bama 33,1 B posts
- 3. Lakers 29,7 B posts
- 4. Oklahoma 48,2 B posts
- 5. #AEWFullGear 77,1 B posts
- 6. Milroe 16,1 B posts
- 7. Texas 144 B posts
- 8. Nuggets 25,2 B posts
- 9. Jokic 17,5 B posts
- 10. War Eagle 2.050 posts
- 11. Aggies 5.525 posts
- 12. UCLA 8.444 posts
- 13. The SEC 185 B posts
- 14. Boomer Sooner 2.404 posts
- 15. DeBoer 4.159 posts
- 16. War Damn Eagle N/A
- 17. Vandy 7.590 posts
- 18. Ryan Williams 3.603 posts
- 19. Westbrook 5.797 posts
- 20. Saban 10,1 B posts
Something went wrong.
Something went wrong.